NASDAQ:BFRI Biofrontera (BFRI) Stock Price, News & Analysis $1.24 +0.14 (+12.73%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.08▼$1.2650-Day Range$0.83▼$1.2452-Week Range$0.61▼$12.56Volume73,525 shsAverage Volume381,178 shsMarket Capitalization$6.31 millionP/E RatioN/ADividend YieldN/APrice Target$18.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Biofrontera alerts: Email Address Biofrontera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,351.6% Upside$18.00 Price TargetShort InterestHealthy1.10% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.21) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.55 out of 5 stars 3.5 Analyst's Opinion Consensus RatingBiofrontera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageBiofrontera has received no research coverage in the past 90 days.Read more about Biofrontera's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.10% of the float of Biofrontera has been sold short.Short Interest Ratio / Days to CoverBiofrontera has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Biofrontera has recently increased by 20.49%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldBiofrontera does not currently pay a dividend.Dividend GrowthBiofrontera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BFRI. Previous Next 3.3 News and Social Media Coverage News SentimentBiofrontera has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Biofrontera this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Biofrontera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Biofrontera is held by insiders.Percentage Held by InstitutionsOnly 10.08% of the stock of Biofrontera is held by institutions.Read more about Biofrontera's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Biofrontera are expected to grow in the coming year, from ($3.21) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Biofrontera is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Biofrontera is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBiofrontera has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Biofrontera's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Biofrontera Stock (NASDAQ:BFRI)Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.Read More BFRI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BFRI Stock News HeadlinesJune 24, 2024 | globenewswire.comBiofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampMay 15, 2024 | msn.comBiofrontera GAAP EPS of -$2.88, revenue of $7.9MJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...March 24, 2024 | investorplace.com3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 MillionMarch 20, 2024 | seekingalpha.comBiofrontera Inc. (BFRI) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call TranscriptMarch 18, 2024 | msn.comBiofrontera GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1.21MFebruary 20, 2024 | msn.comBiofrontera stock soars on announcing private placement of up to $16MJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...February 20, 2024 | finance.yahoo.comBiofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AGJanuary 31, 2024 | finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI): Is Breakeven Near?January 11, 2024 | msn.comBiofrontera sees 19% growth in prelim FY 2023 revenueNovember 22, 2023 | finance.yahoo.comBiofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?November 11, 2023 | finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | finance.yahoo.comBenign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Stock's 50% PlummetNovember 9, 2023 | finance.yahoo.comBiofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNovember 9, 2023 | finance.yahoo.comBiofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should KnowNovember 3, 2023 | finance.yahoo.comBiofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10See More Headlines Receive BFRI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BFRI CUSIPN/A CIK1858685 Webwww.biofrontera-us.com Phone781-245-1325FaxN/AEmployees70Year FoundedN/APrice Target and Rating Average Stock Price Target$18.00 High Stock Price Target$18.00 Low Stock Price Target$18.00 Potential Upside/Downside+1,363.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($13.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,130,000.00 Net Margins-69.44% Pretax Margin-69.41% Return on Equity-1,390.99% Return on Assets-85.45% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio0.94 Sales & Book Value Annual Sales$34.07 million Price / Sales0.18 Cash FlowN/A Price / Cash FlowN/A Book Value$3.16 per share Price / Book0.39Miscellaneous Outstanding Shares5,090,000Free Float5,078,000Market Cap$6.26 million OptionableNo Data Beta0.44 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesDr. Hermann Luebbert Ph.D. (Age 68)CEO, President & Executive Chairman Comp: $733.23kMr. Eugene Frederick Leffler III (Age 39)Chief Financial Officer Comp: $378.58kMs. Erica F. Gates CPAM.B.A., Senior Director of Finance & Principal Accounting OfficerMr. Jon Lyons M.B.A.Ph.D., Vice President of Scientific & Medical AffairsMs. Alycia TorresVice President of AdministrationMr. Daniel Hakansson J.D.General Counsel & Head of ComplianceMs. Samantha WiddicombeSenior Director of Strategic Accounts & CommunicationsMr. Mark BaldygaVice President of Sales & MarketingMore ExecutivesKey CompetitorsCelyad OncologyNASDAQ:CYADCara TherapeuticsNASDAQ:CARATherapeuticsMDNASDAQ:TXMDJanOneNASDAQ:JANiBioNYSE:IBIOView All Competitors BFRI Stock Analysis - Frequently Asked Questions How have BFRI shares performed this year? Biofrontera's stock was trading at $2.77 at the beginning of the year. Since then, BFRI shares have decreased by 55.2% and is now trading at $1.24. View the best growth stocks for 2024 here. How were Biofrontera's earnings last quarter? Biofrontera Inc. (NASDAQ:BFRI) announced its earnings results on Wednesday, May, 15th. The company reported ($1.85) earnings per share for the quarter, missing analysts' consensus estimates of ($1.63) by $0.22. The business had revenue of $7.91 million for the quarter, compared to analysts' expectations of $11.52 million. Biofrontera had a negative trailing twelve-month return on equity of 1,390.99% and a negative net margin of 69.44%. When did Biofrontera's stock split? Biofrontera's stock reverse split on Wednesday, July 5th 2023. The 1-20 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Biofrontera IPO? Biofrontera (BFRI) raised $19 million in an initial public offering (IPO) on Friday, October 29th 2021. The company issued 3,100,000 shares at $5.00-$7.00 per share. Roth Capital Partners and The Benchmark Company served as the underwriters for the IPO. How do I buy shares of Biofrontera? Shares of BFRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BFRI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.